GPT Health Care Limited
IPO Size
`500 Cr
Price Band
NA
Minimum Lot Size
NA
Face Value
`10 Per Share
Employee Discount
NA
Retail Allocation
NA
Issue Open Date
NA
Issue Close Date
NA
Listing Date
IPO Size
Price Band
Minimum Lot Size
Face Value
Employee Discount
Retail Allocation
Issue Open Date
Issue Close Date
Listing Date
GPT healthcare limited was founded in the year 1989, as per the CRISIL report one of the leading regional corporate healthcare companies in Eastern India in terms of the number of beds and hospitals. GPT health care limited operates a chain of mid-sized multispecialty hospitals in Eastern India under the “ILS Hospitals” brand and provides integrated healthcare services, with a focus on secondary and tertiary care. As of 30th September 2021, the firm operates four multispecialty hospitals, with a total capacity of 556 beds.
The hospitals under GPT health care limited offers a range of healthcare services across over 35 specialties and super specialties, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynecology and obstetrics, critical care, gastroenterology, orthopedics, and joint replacements, interventional cardiology, neurology, neurosurgery, pediatrics, and neonatology. Hospital also provides integrated diagnostic services and pharmacies
The Managing Director Dr. Om Tantiais the founder of ILS Hospitals and is an established name in the field of laparoscopic surgery. He has more than 40 years of experience in minimal access surgery and established ILS Hospitals in the year 2000 with the vision of providing quality healthcare services in Eastern India.
| S.No. | 1 - Company | 2 - Directors | 3 - Promoters | |||
| Entity Name | By the Company | Against the Company | By the Director | Against the Director | By the Promoter | Against the Promoter |
| Criminal cases | 4 | 2 | - | 1 | - | 3 |
| Material civil cases | 1 | 8 | - | 1 | - | 3 |
| Taxation matters | - | - | - | - | 2 | - |
| Regulatory Procedings | - | - | - | - | - |
- |
|
Income Statement |
FY21 |
FY20 |
FY19 |
|
Gross Operating Income |
2488.63 |
2160.78 |
1747.33 |
|
Cost of Employee & Inventory |
416.62 |
420.38 |
309.84 |
|
Other Expenses |
1937.62 |
1760.44 |
1349.01 |
|
EBITDA |
551.01 |
400.34 |
398.32 |
|
Depreciation |
124.72 |
110.8 |
89.95 |
|
Interest |
137.46 |
141.15 |
104.58 |
|
Profit Before Tax |
288.83 |
148.39 |
203.79 |
|
Tax |
77.9 |
38.83 |
54.27 |
|
Profit After Tax |
210.93 |
109.96 |
149.52 |
GPT SONS PRIVATE LIMITED
• Apollo Hospitals Enterprise Limited (AGHL), AMRI • Hospitals (AMRI), • Medica Hospitals (MDHS), • Neotia Healthcare • Initiative Limited (NHIL), • Peerless Hospitex Hospital • Research Center Limited (PHHR).
The company will not receive any proceeds by selling 29.89 million equity shares available under offer for Sale.
The company will issue its net proceeds from fresh issues for the following:- • Purchase of medical equipment; • General corporate purposes.